Ticker

NEW YORK, April 29, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced that it will hold a conference call on Wednesday, May 13, 2026, at 5:00 p.m. ET following the release of its first quarter 2026 financial results.

AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease diagnostics and disease management tools, today announced it is completing the buildout of its molecular laboratory in Q2 2026, marking a major operational milestone that accelerates development and future…

Delivered Q4 2025 and FY 2025 revenue of $120.5 million and $500.6 million Expanded Adjusted EBITDA Margin 1  to 25.1% in Q4 2025 and 23.4% for FY 2025 Maintained strong liquidity with $ 85.7 million in cash and no significant near-term debt Retail footprint reaches 48 locations as densification continues NEW YORK, March 12, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE:…

Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million Balance sheet strength with $86 million cash and no significant debt maturities until 2029 Q4 & FY 2025 earnings call scheduled for Thursday, March 12, at 5:00 PM ET NEW YORK, Feb. 9, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH",…